Standigm Company
Standigm is an AI-driven workflow drug discovery company that aims to improve the success rates and efficiency of new drug development.
Investors
Technology:
Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Pharmaceutical
Industry:
AI, Drug Repurposing, Early Drug Development
Headquarters:
Seoul, Seoul-t'ukpyolsi, South Korea
Founded Date:
2015-05-04
Employees Number:
101-250
Funding Status:
Late Stage Venture
Investors Number:
15
Total Funding:
71240000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-06-30
Last Funding Type:
Series D
Register and Claim Ownership